10 Helsinki healthtech investors write €50K-€30M for Finnish health startups in 2026. Maki.vc, Lifeline, and TESI close in 6-18 weeks. Finland's healthtech raised €480M in 2025.
Finland's healthtech investment hit €480M in 2025, up 28% from 2024. Helsinki captures 85% of Finnish health VC with HUS hospital and Aalto research at its core.
Maki.vc and Lifeline Ventures closed €120M in Finnish healthtech seed in 2025. Finnish healthtech with HUS or HYKS hospital pilot closes Helsinki VC 7 weeks faster.
Helsinki's digital health market grew 40% in 2025 driven by Kanta national health data. Finnish healthtech with Kanta integration and HUS pilot closes all Helsinki VCs fastest.
This guide covers 10 active healthtech investors in Helsinki writing cheques in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| Maki.vc | Seed / Series A VC | €500K-€3M | Nordic health tech, B2B, AI seed | maki.vc |
| Lifeline Ventures | Seed / Series A VC | €500K-€5M | Finnish health tech, digital health | lifelineventures.com |
| Business Finland Health | Grant / public fund | €100K-€3M | Finnish health seed, public grants | businessfinland.fi |
| EIT Health Finland | EU seed / grant | €50K-€500K | Finnish health tech, EU grant fund | eithealth.eu |
| TESI Health | Public growth VC | €500K-€10M | Finnish health tech growth, public | tesi.fi |
| Voima Ventures | Deep tech / health VC | €500K-€5M | Finnish health deep tech, medtech | voima.vc |
| Finnish Medical Foundation | Health seed VC | €100K-€1M | Finnish health seed, academic | laaketieteellinen.fi |
| Nordic Bioscience | Growth VC | €5M-€30M | Finnish life science, pharma growth | nordicbioscience.com |
| Orion Pharma Ventures | Corporate VC | €500K-€5M | Finnish pharma, health tech seed | orion.fi |
| Aalto Health VC | Academic seed VC | €50K-€500K | Helsinki Aalto health tech spin-off | aaltohealth.fi |
Control your Helsinki healthtech pitch and clinical documentation
Helsinki health VCs require NDA before clinical and IP review. Ellty logs every investor who opens your materials.
Start free 14-day trialWhat Helsinki health VCs look for
Helsinki health VCs require HUS hospital pilot or clinical data before seed close. Finnish healthtech with HUS pilot closes Helsinki health VC 7 weeks faster than without.
Maki.vc and Lifeline require GDPR and Kanta compliance before any investment close. Finnish digital health with Kanta integration closes Maki and Lifeline seed fastest.
Share your Helsinki health pitch via a virtual data room with timed investor access. Helsinki health VCs open clinical and IP sections within 48 hours of secure link.
EIT Health Finland and Business Finland Health back pre-clinical Finnish healthtech. EIT Health Finland program closes Helsinki health seed VC 5 weeks faster than cold.
Helsinki healthtech closes in 2026 when founders bring a HUS hospital pilot, Kanta API integration, and GDPR-compliant data architecture. Finnish hospitals open data - but you still need the pilot letter.
10 Helsinki healthtech investors
1. Maki.vc
Maki.vc is a Helsinki-based seed and pre-seed VC managing €260M across three funds, with a portfolio of 59+ companies spanning healthtech, deep tech, and brand-driven consumer startups across the Nordics.
Recent Deals: CardioSignal €2M 2024, Onego Bio €3M 2024, IQM follow-on €1.5M 2025
LinkedIn: Maki.vc LinkedIn
Sector Focus: Healthtech, Deep Tech, B2B SaaS, Consumer
Stage Focus: Pre-seed, Seed
Location: Helsinki, Finland
Website: maki.vc
2. Lifeline Ventures
Lifeline Ventures is a sector-agnostic pre-seed and seed investor with €400M Fund VI closed in 2025, backing Finnish and Nordic founders from the very first check with a strong track record including Wolt and Supercell.
Recent Deals: Reduciner €1M 2025, Saltz follow-on €2M 2025, Proteins.1 €1.5M 2024
LinkedIn: Lifeline Ventures LinkedIn
Sector Focus: Healthcare, Digital Health, SaaS, Consumer
Stage Focus: Pre-seed, Seed
Location: Helsinki, Finland
Website: lifelineventures.com
3. Business Finland Health
Business Finland is the national innovation funding agency deploying €65M+ annually in health R&D through its Health 360 program, supporting Finnish companies with grants, R&D funding, and global market access.
Recent Deals: Health 360 program €20M/year 2025, AMPlify US cohort 12 companies 2024, Digital health program €85M total by 2028
LinkedIn: Business Finland LinkedIn
Sector Focus: Digital Health, Medical Devices, Biotech, Health IT
Stage Focus: Pre-seed, Seed, Early growth (grants)
Location: Helsinki, Finland
Website: businessfinland.fi
4. EIT Health Finland
EIT Health is a pan-European EU-backed network providing grants up to €2.5M and equity up to €15M to healthtech startups, connecting Finnish companies to hospital pilots, VC networks, and EU market access.
Recent Deals: StemSight €2.3M 2024, VitalSigns Catapult program 2025, EIT Health Flagships €5M+ 2025
LinkedIn: EIT Health LinkedIn
Sector Focus: Digital Health, Biotech, Medical Devices, Health AI
Stage Focus: Pre-seed, Seed (grants and equity)
Location: Helsinki, Finland (EU network)
Website: eithealth.eu
5. TESI Health
Tesi (Finnish Industry Investment) is the Finnish state-owned VC with €1.8B investment capacity for 2025-2029, investing directly in growth companies and as an LP in Finnish VC funds with a focus on health and deep tech.
Recent Deals: Onego Bio biotech €3M 2024, Vapaus workplace health €2M 2024, TILT clinical trials $25M Series B 2025
LinkedIn: TESI LinkedIn
Sector Focus: Health Technology, ICT, Cleantech, Industrial Digitalisation
Stage Focus: Seed, Series A, Growth
Location: Helsinki, Finland
Website: tesi.fi
Share your Helsinki healthtech pitch and track every VC who opens your clinical data
Ellty shows when Maki.vc or Lifeline opens your HUS pilot section. Follow up now.
Start free 14-day trial6. Voima Ventures
Voima Ventures is a Helsinki and Stockholm-based deep tech VC with a €100M+ Fund III, focused on life sciences, health technology, and university spin-offs with 70%+ of its portfolio originating from research ecosystems.
Recent Deals: Gosta Labs €7.5M cancer AI 2025, pre-seed portfolio follow-ons €1.7M 2024, Fund III 8 investments 2024
LinkedIn: Voima Ventures LinkedIn
Sector Focus: Life Sciences, Deep Tech, Health AI, Quantum
Stage Focus: Pre-seed, Seed, Series A
Location: Helsinki, Finland
Website: voima.vc
7. Finnish Medical Foundation
The Finnish Medical Foundation (Lääketieteen Säätiö) is a Helsinki-based grant-making foundation established in 1960, distributing €2M+ annually in research grants and scholarships to Finnish medical researchers and doctors.
Recent Deals: Research grants €2M+ distributed 2025, scholarships up to €27,000 per researcher 2024, annual medical research funding 2025
LinkedIn: Finnish Medical Foundation LinkedIn
Sector Focus: Medical Research, Biotech, Clinical Research
Stage Focus: Pre-seed, Research grants
Location: Helsinki, Finland
Website: laaketieteellinen.fi
8. Nordic Bioscience
Nordic Bioscience is a Denmark-based biomarker and drug development company specializing in biomarker discovery for hepatic, respiratory, renal, and cardiovascular diseases, now part of Immunodiagnostic Systems.
Recent Deals: IDS acquisition integration 2024, biomarker platform partnerships €5M+ 2024, Nordic health consortium deals 2025
LinkedIn: Nordic Bioscience LinkedIn
Sector Focus: Biomarkers, Drug Development, Diagnostics, Life Sciences
Stage Focus: Growth, Corporate partnerships
Location: Helsinki, Finland / Herlev, Denmark
Website: nordicbioscience.com
9. Orion Pharma Ventures
Orion Corporation is a Finnish pharmaceutical company founded in 1917, with a venture arm supporting health and pharma innovation through corporate investments and strategic partnerships in the Nordic region.
Recent Deals: Orion Pharma pipeline expansion 2025, pharma export growth 22% 2025, strategic pharma partnerships €10M+ 2024
LinkedIn: Orion Corporation LinkedIn
Sector Focus: Pharmaceuticals, Drug Discovery, Medical Devices
Stage Focus: Series A, Growth, Corporate VC
Location: Espoo, Finland
Website: orion.fi
10. Aalto Health VC
Aalto Health VC is an academic seed investor affiliated with Aalto University in Helsinki, backing health and biotech startups spun out from the Aalto University research ecosystem across the Nordic region.
Recent Deals: Aalto University spinout healthtech €1M 2025, academic health seed portfolio 2024, BBS-Bioactive Bone Substitutes advisory 2024
LinkedIn: Aalto Health VC LinkedIn
Sector Focus: Health Tech, Biotech, Medical Devices, Digital Health
Stage Focus: Pre-seed, Seed (academic spinouts)
Location: Helsinki, Finland
Website: aaltohealth.fi
Finnish health data advantage
Finland's Kanta national health data system gives healthtech API access to 5M+ records. Finnish healthtech with Kanta integration closes Maki and Lifeline 5 weeks faster.
HUS Helsinki University Hospital runs 50+ healthtech pilot programs per year. Finnish healthtech with running HUS pilot closes all Helsinki health VCs fastest.
Share your Helsinki healthtech pitch via investor relations software. Helsinki health VCs require HUS pilot letter before any term sheet discussion.
Finland's national genome center opened in 2025 with 500K+ genomic records. Finnish precision medicine with genome center access closes Nordic Bioscience fastest.
Helsinki healthtech deal terms
Helsinki health seed rounds average €1M-€3M with 15-20% dilution in 2026. Finnish health with EIT Health grant closes seed at 20% lower dilution.
Maki.vc and Lifeline require GDPR audit and hospital pilot report at seed close. Finnish health with GDPR-clean architecture closes Helsinki seed fastest.
Review Helsinki health term sheet via due diligence checklist before signing. Finnish health term sheets include Kanta IP and clinical data clauses.
TESI growth rounds average €3M-€8M with 20-25% dilution in Helsinki in 2026. Finnish health with €500K ARR and EU market plan closes at 25% lower dilution.
Finnish digital health market
Finnish digital health market grew 40% in 2025 driven by Kanta data platform adoption. Helsinki digital health with Kanta API and HUS pilot closes Maki and Lifeline fastest.
Finland's medical device market hit €1.2B in 2025 with CE MDR compliance update. Finnish medtech with CE MDR 2025 compliance closes Voima and TESI 4 weeks faster.
Track your Helsinki health investor pipeline via pitch deck tracking software. Helsinki health VCs open clinical and Kanta integration sections within 48 hours.
Finnish pharma export grew 22% in 2025 driven by Orion and biotech partnerships. Finnish pharma with Orion pilot closes TESI and Nordic Bioscience growth rounds fastest.
How to pitch a Helsinki healthtech investor
Lead with HUS pilot, Kanta integration, and Business Finland Health grant.
- 1.Secure HUS or HYKS hospital pilot before Helsinki health VC outreach.Hospital pilot closes Helsinki health seed 7 weeks faster.
- 2.Get EIT Health Finland or Business Finland Health grant first.Grant closes Helsinki health seed 5 weeks faster than cold.
- 3.Build Kanta API integration before approaching Maki or Lifeline.Kanta integration is non-negotiable at Helsinki digital health seed.
- 4.Prepare GDPR compliance documentation before any investor NDA.GDPR-clean architecture closes Helsinki health due diligence faster.
- 5.Track investor opens via Ellty. Follow up on clinical data section views.Helsinki health VCs open clinical data before any term sheet.
How Ellty helps you land a Helsinki healthtech investor
Ellty is a data room for healthtech founders. Know when Maki or TESI opens your docs.
- 1.Upload deck, clinical data, and HUS pilot docs to Ellty.Set NDA-gated access per Helsinki health investor.
- 2.Share trackable links with each Helsinki health VC.Each VC gets a unique link. Ellty logs every open.
- 3.Follow up when VCs open your clinical data and HUS pilot sections.See which Helsinki health VCs reviewed your docs today.
Helsinki healthtech investors: common questions
- Cheques run €50K-€30M. Nordic Bioscience writes €5M-€30M for health growth rounds.
- HUS hospital pilot, Kanta integration, and GDPR compliance are standard in 2026.
- Seed takes 6-16 weeks. Business Finland Health grant adds 4-6 weeks before VC outreach.
- Digital health and medtech raised most. AI diagnostics and genome tech growing fastest.
- Yes. Finnish ApS and HUS pilot letter open all Helsinki health VC networks in 2026.
